Hendley & CO Inc Astrazeneca PLC Transaction History

Hendley & CO Inc

$302 Million
Q3 2025

A detailed history of Hendley & CO Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Hendley & CO Inc holds 73,220 shares of AZN stock, worth $6.55 Million. This represents 1.86% of its overall portfolio holdings.

Number of Shares

73,220

Previous 73,690 0.64%

Holding current value

$6.55 Million

Previous $5.15 Million 9.09%

% of portfolio

1.86%

Previous 1.8%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$68.72 - $82.11 $32,298 - $38,591	-470 Reduced 0.64%	73,220 $5.62 Million
Q2 2025 Jul 23, 2025	BUY	$64.87 - $75.0 $42,165 - $48,750	650 Added 0.89%	73,690 $5.15 Million
Q1 2025 Apr 29, 2025	BUY	$65.37 - $77.96 $1.72 Million - $2.05 Million	26,260 Added 56.14%	73,040 $5.37 Million
Q4 2024 Feb 04, 2025	BUY	$63.2 - $79.58 $45,504 - $57,297	720 Added 1.56%	46,780 $3.07 Million
Q3 2024 Oct 31, 2024	SELL	$76.67 - $87.62 $11,500 - $13,143	-150 Reduced 0.32%	46,060 $3.59 Million

Q2 2024 Jul 16, 2024	SELL	$66.81 - $80.83 $26,724 - $32,332	-400 Reduced 0.86%	46,210 $3.6 Million
Q4 2023 Jan 26, 2024	SELL	$61.89 - $69.28 $3,094 - $3,464	-50 Reduced 0.11%	46,610 $3.14 Million
Q3 2023 Oct 25, 2023	BUY	$64.85 - $71.7 $2.7 Million - $2.99 Million	41,660 Added 833.2%	46,660 $3.16 Million
Q1 2021 Apr 22, 2021	SELL	$47.16 - $54.44 $188,640 - $217,760	-4,000 Reduced 44.44%	5,000 $249,000
Q3 2020 Oct 21, 2020	BUY	$53.07 - $61.1 $477,630 - $549,900	9,000 New	9,000 $493,000

Others Institutions Holding AZN

# of Institutions

1,498

Shares Held

500M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hendley & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hendley & CO Inc with notifications on news.

Account